SYNERGISM OF THE ANALGESIC ACTIVITY OF METAMIZOLE SODIUM WITH KETAMINE AND DEXMEDETOMIDINE IN MULTIMODAL ANALGESIA IN A MODEL OF ACUTE VISCERAL PAIN
ARTICLE PDF

Keywords

analgesia
multimodal
pain
visceral
metamizole
ketamine
dexmedetomidine
analgesics
non-narcotic

How to Cite

Matvieienko, M. V., Chyzh, M. O., Hladkykh, F. V., Basarab, O. V., & Gogiya, M. O. (2026). SYNERGISM OF THE ANALGESIC ACTIVITY OF METAMIZOLE SODIUM WITH KETAMINE AND DEXMEDETOMIDINE IN MULTIMODAL ANALGESIA IN A MODEL OF ACUTE VISCERAL PAIN. Clinical and Preventive Medicine, (3), 71-80. https://doi.org/10.31612/2616-4868.3.2026.08

Abstract

Introduction. Multimodal analgesia is a cornerstone of opioid-sparing strategies for acute pain management. Metamizole is a widely used non-opioid analgesic with combined peripheral and central mechanisms; however, its potentiation by central adjuvants requires further experimental validation.

Aim. To evaluate and compare the analgesic efficacy of metamizole administered alone and in combination with central adjuvants (gabapentin, pregabalin, ketamine, amitriptyline, dexmedetomidine) in mice, and to identify regimens providing the greatest enhancement relative to monotherapy and an opioid reference.

Materials and methods. Male mice (n=91) were randomized into 13 groups (7 animals each). Acute visceral pain was modeled using the acetic acid–induced writhing test. Antinociceptive activity was quantified by counting pain-related behaviors. Results were compared with intact controls, an opioid control, and monotherapy regimens.

Results. Metamizole sodium (MM-Na) monotherapy significantly reduced writhing to 28 [22;33], corresponding to a 48.1% decrease versus control (p < 0.001). Addition of central adjuvants produced heterogeneous effects. Combinations with gabapentin, pregabalin, or amitriptyline reduced writhes to 22 [19;32], 20 [18;22], and 20 [18;23], corresponding to 59.3–63.0% inhibition; however, superiority over MM-Na alone did not consistently reach statistical significance (p = 0.22–0.08). In contrast, MM-Na plus ketamine significantly potentiated analgesia, decreasing writhes to 17 [15;21] (–68.5% vs control; –39.3% vs MM-Na, p=0.01). The most pronounced effect was observed with MM-Na plus dexmedetomidine (13 [12;18] writhes; –75.9%), statistically comparable to morphine (p = 0.45) and significantly superior to MM-Na monotherapy (p = 0.01), indicating near-opioid-level analgesia within a non-opioid multimodal approach.

Conclusions. Metamizole is a rational basic component of multimodal analgesia. Dexmedetomidine and ketamine demonstrated the greatest potential for enhancing its analgesic effect in this experimental model.

https://doi.org/10.31612/2616-4868.3.2026.08
ARTICLE PDF

References

Gut, S., Rauch, M., Haschke, M., Huber, C. A., Gaertner, J., Schur, N., Meier, C. R., & Spoendlin, J. (2024). Use of metamizole and other non-opioid analgesics in Switzerland between 2014 and 2019: an observational study using a large health insurance claims database. Swiss medical weekly, 154, 3535. https://doi.org/10.57187/s.3535

Hoffmann, F., Bantel, C., von Rosen, F. T., & Jobski, K. (2020). Regional Differences in Prescribing Patterns of Metamizole in Germany Based on Data from 70 Million Persons. International journal of environmental research and public health, 17(11), 3892. https://doi.org/10.3390/ijerph17113892

Cascorbi, I., & Baron, R. (2026). Metamizole: Indications and Risks. Deutsches Arzteblatt international, (Forthcoming), arztebl.m2025.0214. Advance online publication. https://doi.org/10.3238/arztebl.m2025.0214

Zinzi, A., Gaio, M., Ruggiero, D., Riccardi, C., Cagnotta, C., Pentella, C., Capuano, A., & Rafaniello, C. (2025). A systematic review and pharmacovigilance analysis of the risk of agranulocytosis associated with metamizole use. Scientific reports, 15(1), 42796. https://doi.org/10.1038/s41598-025-27009-6

Fidelis, G. F. S., Dagli-Hernandez, C., Martinelli, R. P., Marzuki, J. E., Baharuddin, B., Yue, Q. Y., Edwards, B., Pincinato, E. C., & Moriel, P. (2025). Pharmacogenetics of metamizole-induced agranulocytosis: a systematic review and drug regulation implications. Frontiers in pharmacology, 16, 1624044. https://doi.org/10.3389/fphar.2025.1624044

Stamer, U. M., Gundert-Remy, U., Biermann, E., Erlenwein, J., Meiβner, W., Wirz, S., & Stammschulte, T. (2017). Metamizol : Überlegungen zum Monitoring zur frühzeitigen Diagnose einer Agranulozytose [Dipyrone (metamizole) : Considerations on monitoring for early detection of agranulocytosis]. Schmerz (Berlin, Germany), 31(1), 5–13. https://doi.org/10.1007/s00482-016-0160-3

Hearn, L., Derry, S., & Moore, R. A. (2016). Single dose dipyrone (metamizole) for acute postoperative pain in adults. The Cochrane database of systematic reviews, 4(4), CD011421. https://doi.org/10.1002/14651858.CD011421.pub2

Romanowski, K. S., Carson, J., Pape, K., Bernal, E., Sharar, S., Wiechman, S., Carter, D., Liu, Y. M., Nitzschke, S., Bhalla, P., Litt, J., Przkora, R., Friedman, B., Popiak, S., Jeng, J., Ryan, C. M., & Joe, V. (2020). American Burn Association Guidelines on the Management of Acute Pain in the Adult Burn Patient: A Review of the Literature, a Compilation of Expert Opinion, and Next Steps. Journal of burn care & research : official publication of the American Burn Association, 41(6), 1129–1151. https://doi.org/10.1093/jbcr/iraa119

Jeyaraman, N., Migliorini, F., Murugan, S., Ramasubramanian, S., Balaji, S., Maffulli, N., & Jeyaraman, M. (2024). Metamizole in the Management of Musculoskeletal Disorders: Current Concept Review. Journal of clinical medicine, 13(16), 4794. https://doi.org/10.3390/jcm13164794

Alnajar, M., Saker, Z., Haji, F., Abdelsamed, M. A., Khaled, Z., & Abd-ElGawad, M. (2024). Antipyretic effect of oral dipyrone (Metamizole) compared to oral ibuprofen in febrile children: a systematic review and meta-analysis. BMC pediatrics, 24(1), 634. https://doi.org/10.1186/s12887-024-05095-1

Schüchen, R. H., Mücke, M., Marinova, M., Kravchenko, D., Häuser, W., Radbruch, L., & Conrad, R. (2018). Systematic review and meta-analysis on non-opioid analgesics in palliative medicine. Journal of cachexia, sarcopenia and muscle, 9(7), 1235–1254. https://doi.org/10.1002/jcsm.12352

Brinkman, D. J., Hendriksen, L. C., Rigter, I. M., & Hollmann, M. W. (2025). Pharmacology and relevant drug interactions of metamizole. British journal of clinical pharmacology, 91(7), 2095–2102. https://doi.org/10.1002/bcp.70101

Collares, E. F., & Troncon, L. E. A. (2019). Effects of dipyrone on the digestive tract. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica, 52(2), e8103. https://doi.org/10.1590/1414-431X20188103

Metamizole [Dipyrone]. (2025). In LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. National Institute of Diabetes and Digestive and Kidney Diseases.

Weber, S., Erhardt, F., Allgeier, J., Saka, D., Donga, N., Neumann, J., Lange, C. M., & Gerbes, A. L. (2025). Drug-Induced Liver Injury Caused by Metamizole: Identification of a Characteristic Injury Pattern. Liver international : official journal of the International Association for the Study of the Liver, 45(3), e70012. https://doi.org/10.1111/liv.70012

Petermichl, W., Ellmauer, P. P., Benning, A., Zeman, F., Schmid, C., Stadlbauer, A., Heimerl, S., Seyfried, T., & Blecha, S. (2025). Impact of Dipyrone Administration on Postoperative Analgesia and Aspirin Effect in Patients Undergoing Coronary Artery Bypass Grafting: The Prospective Randomized DipASA Study. Journal of cardiothoracic and vascular anesthesia, 39(1), 121–130. https://doi.org/10.1053/j.jvca.2024.10.009

Kleine-Borgmann, J., Wilhelmi, J., Kratel, J., Baumann, F., Schmidt, K., Zunhammer, M., & Bingel, U. (2021). Tilidine and dipyrone (metamizole) in cold pressor pain: A pooled analysis of efficacy, tolerability, and safety in healthy volunteers. Clinical and translational science, 14(5), 1997–2007. https://doi.org/10.1111/cts.13058

Kaye, A. D., Chernobylsky, D. J., Thakur, P., Siddaiah, H., Kaye, R. J., Eng, L. K., Harbell, M. W., Lajaunie, J., & Cornett, E. M. (2020). Dexmedetomidine in Enhanced Recovery After Surgery (ERAS) Protocols for Postoperative Pain. Current pain and headache reports, 24(5), 21. https://doi.org/10.1007/s11916-020-00853-z

Mestdagh, F. P., Lavand'homme, P. M., Pirard, G., Joshi, G. P., Sauter, A. R., Van de Velde, M., & PROSPECT Working Group∗ of the European Society of Regional Anaesthesia and Pain Therapy (ESRA) (2023). Pain management after elective craniotomy: A systematic review with procedure-specific postoperative pain management (PROSPECT) recommendations. European journal of anaesthesiology, 40(10), 747–757. https://doi.org/10.1097/EJA.0000000000001877

American Veterinary Medical Association. AVMA guidelines for the euthanasia of animals: 2020 edition. Schaumburg (IL): American Veterinary Medical Association; 2020. 121 p. Available from: https://www.avma.org/sites/default/files/2020-02/Guidelines-on-Euthanasia-2020.pdf

Gawade S. P. (2012). Acetic acid induced painful endogenous infliction in writhing test on mice. Journal of pharmacology & pharmacotherapeutics, 3(4), 348. https://doi.org/10.4103/0976-500X.103699

Stefanov, O. V. (Ed.). (2001). Preclinical studies of medicinal products: Methodical recommendations. Kyiv: Avicenna. 527 p. Available at: https://pubmed.com.ua/xmlui/handle/123456789/77 [in Ukrainian]

Kharasch, E. D., Clark, J. D., & Kheterpal, S. (2020). Perioperative Gabapentinoids: Deflating the Bubble. Anesthesiology, 133(2), 251–254. https://doi.org/10.1097/ALN.0000000000003394

Hannon, C. P., Fillingham, Y. A., Browne, J. A., Schemitsch, E. H., Mullen, K., Casambre, F., Visvabharathy, V., Hamilton, W. G., & Della Valle, C. J. (2020). The Efficacy and Safety of Gabapentinoids in Total Joint Arthroplasty: Systematic Review and Direct Meta-Analysis. The Journal of arthroplasty, 35(10), 2730–2738.e6. https://doi.org/10.1016/j.arth.2020.05.033

Moore, R. A., Derry, S., Aldington, D., Cole, P., & Wiffen, P. J. (2015). Amitriptyline for neuropathic pain in adults. The Cochrane database of systematic reviews, 2015(7), CD008242. https://doi.org/10.1002/14651858.CD008242.pub3

Obata H. (2017). Analgesic Mechanisms of Antidepressants for Neuropathic Pain. International journal of molecular sciences, 18(11), 2483. https://doi.org/10.3390/ijms18112483

Schwenk, E. S., & Mariano, E. R. (2018). Designing the ideal perioperative pain management plan starts with multimodal analgesia. Korean journal of anesthesiology, 71(5), 345–352. https://doi.org/10.4097/kja.d.18.00217

Lampl, C., & Likar, R. (2014). Metamizol: Wirkmechanismen, Interaktionen und Agranulozytoserisiko [Metamizole (dipyrone): mode of action, drug-drug interactions, and risk of agranulocytosis]. Schmerz (Berlin, Germany), 28(6), 584–590. https://doi.org/10.1007/s00482-014-1490-7

Jasiecka, A., Maślanka, T., & Jaroszewski, J. J. (2014). Pharmacological characteristics of metamizole. Polish journal of veterinary sciences, 17(1), 207–214. https://doi.org/10.2478/pjvs-2014-0030

Viderman, D., Aubakirova, M., Nemerenova, A., Salamat, A., & Abdildin, Y. G. (2024). The Effects of Dexmedetomidine on Pain-Related Outcomes in Craniotomy: A Systematic Review and Meta-Analysis. World neurosurgery, 190, e93–e108. https://doi.org/10.1016/j.wneu.2024.07.034

Tomaszek, L., Fenikowski, D., Maciejewski, P., Komotajtys, H., & Gawron, D. (2020). Perioperative Gabapentin in Pediatric Thoracic Surgery Patients-Randomized, Placebo-Controlled, Phase 4 Trial. Pain medicine (Malden, Mass.), 21(8), 1562–1571. https://doi.org/10.1093/pm/pnz207

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.